April 29, 2024 News by Lindsey Shapiro, PhD Specialized PET scan shows chronic inflammation tied to MS progression A specialized imaging approach was able to detect signs of persistent inflammation in the brains of people with multiple sclerosis (MS) that aren’t readily captured by standard MRI scans. This so-called smoldering inflammation was also observed among those patients taking high-efficacy disease-modifying therapies (DMTs), where a higher degree…
April 29, 2024 News by Marisa Wexler, MS Lower vidofludimus calcium dose not as effective in RRMS trial A lower dose of the experimental oral therapy vidofludimus calcium (IMU-838) was not as effective as higher doses at reducing lesions in people with relapsing-remitting multiple sclerosis (RRMS), extended data from the therapy’s Phase 2 EMPhASIS trial show. “We found that doses of 30 mg and 45 mg,…
April 26, 2024 Columns by Susan Payrovi, MD Why we should go with the flow of our biological clocks What’s a reliable way to wreck your mood? Fighting your circadian rhythms. I’m a recovering night owl. I used to get more done between 10 p.m. and 2 a.m. than I did in the other 20 hours of the day. I routinely studied past 2 a.m. during college and…
April 26, 2024 News by Margarida Maia, PhD Employment, income drop steadily over 2 decades after onset of MS For people who develop multiple sclerosis (MS), the disease can exact a toll on their ability to work and on how much they earn in the private sector, according to a study by researchers in France, who said policies need to be enacted to replace lost income. “The effects…